search icon
lsta-img

Lisata Therapeutics Inc., Common Stock

LSTA

NAQ

$3.64

-$0.03

(-0.82%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$30.56M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
35.64K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.22
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.19 L
$4.2 H
$3.64

About Lisata Therapeutics Inc., Common Stock

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameLSTASectorS&P500
1-Week Return-2.41%0.31%-1.26%
1-Month Return39.51%0.6%-4.16%
3-Month Return24.66%-9.44%-0.46%
6-Month Return-0.27%-5.15%3.58%
1-Year Return20.53%0.33%22.47%
3-Year Return-70.42%4.53%25.13%
5-Year Return-92.82%35.98%77.7%
10-Year Return-99.36%100.72%190.12%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue---121.37M-[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue65.00K63.00K55.00K57.60M189.00K[{"date":"2019-12-31","value":0.11,"profit":true},{"date":"2020-12-31","value":0.11,"profit":true},{"date":"2021-12-31","value":0.1,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":0.33,"profit":true}]
Gross Profit(65.00K)(63.00K)(55.00K)63.77M(189.00K)[{"date":"2019-12-31","value":-0.1,"profit":false},{"date":"2020-12-31","value":-0.1,"profit":false},{"date":"2021-12-31","value":-0.09,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-0.3,"profit":false}]
Gross Margin(Infinity%)(Infinity%)(Infinity%)52.54%(Infinity%)[{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses20.09M19.14M29.05M57.60M25.71M[{"date":"2019-12-31","value":34.88,"profit":true},{"date":"2020-12-31","value":33.24,"profit":true},{"date":"2021-12-31","value":50.43,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":44.63,"profit":true}]
Operating Income(20.09M)(19.14M)(29.05M)(57.60M)(25.71M)[{"date":"2019-12-31","value":-2009200000,"profit":false},{"date":"2020-12-31","value":-1914500000,"profit":false},{"date":"2021-12-31","value":-2905000000,"profit":false},{"date":"2022-12-31","value":-5760100000,"profit":false},{"date":"2023-12-31","value":-2570800000,"profit":false}]
Total Non-Operating Income/Expense740.00K----[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income(19.35M)(19.01M)(28.97M)(56.70M)(23.17M)[{"date":"2019-12-31","value":-1935200000,"profit":false},{"date":"2020-12-31","value":-1901300000,"profit":false},{"date":"2021-12-31","value":-2897400000,"profit":false},{"date":"2022-12-31","value":-5670400000,"profit":false},{"date":"2023-12-31","value":-2317000000,"profit":false}]
Income Taxes749.00K(10.87M)(1.51M)(2.48M)(2.33M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-1451.54,"profit":false},{"date":"2021-12-31","value":-201.34,"profit":false},{"date":"2022-12-31","value":-330.97,"profit":false},{"date":"2023-12-31","value":-311.08,"profit":false}]
Income After Taxes(20.10M)----[{"date":"2019-12-31","value":-2010100000,"profit":false},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(19.35M)(8.14M)(27.47M)(54.23M)(20.84M)[{"date":"2019-12-31","value":-1935200000,"profit":false},{"date":"2020-12-31","value":-814100000,"profit":false},{"date":"2021-12-31","value":-2746600000,"profit":false},{"date":"2022-12-31","value":-5422500000,"profit":false},{"date":"2023-12-31","value":-2084000000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(20.10M)(8.14M)(27.47M)(54.23M)(20.84M)[{"date":"2019-12-31","value":-2010100000,"profit":false},{"date":"2020-12-31","value":-814100000,"profit":false},{"date":"2021-12-31","value":-2746600000,"profit":false},{"date":"2022-12-31","value":-5422500000,"profit":false},{"date":"2023-12-31","value":-2084000000,"profit":false}]
EPS (Diluted)(28.05)(6.75)(7.80)(11.34)(2.58)[{"date":"2019-12-31","value":-2805,"profit":false},{"date":"2020-12-31","value":-675,"profit":false},{"date":"2021-12-31","value":-780,"profit":false},{"date":"2022-12-31","value":-1134,"profit":false},{"date":"2023-12-31","value":-258,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

LSTA
Cash Ratio 7.64
Current Ratio 8.03

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

LSTA
ROA (LTM) -28.72%
ROE (LTM) -44.03%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

LSTA
Debt Ratio Lower is generally better. Negative is bad. 0.12
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.88

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

LSTA
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.91
Price/FCF NM
EV/R 0.00
EV/Ebitda 0.82

FAQs

What is Lisata Therapeutics Inc. share price today?

Lisata Therapeutics Inc. (LSTA) share price today is $3.64

Can Indians buy Lisata Therapeutics Inc. shares?

Yes, Indians can buy shares of Lisata Therapeutics Inc. (LSTA) on Vested. To buy Lisata Therapeutics Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in LSTA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Lisata Therapeutics Inc. be purchased?

Yes, you can purchase fractional shares of Lisata Therapeutics Inc. (LSTA) via the Vested app. You can start investing in Lisata Therapeutics Inc. (LSTA) with a minimum investment of $1.

How to invest in Lisata Therapeutics Inc. shares from India?

You can invest in shares of Lisata Therapeutics Inc. (LSTA) via Vested in three simple steps:

  • Click on Sign Up or Invest in LSTA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Lisata Therapeutics Inc. shares
What is Lisata Therapeutics Inc. 52-week high and low stock price?

The 52-week high price of Lisata Therapeutics Inc. (LSTA) is $4.2. The 52-week low price of Lisata Therapeutics Inc. (LSTA) is $2.19.

What is Lisata Therapeutics Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Lisata Therapeutics Inc. (LSTA) is

What is Lisata Therapeutics Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Lisata Therapeutics Inc. (LSTA) is 0.91

What is Lisata Therapeutics Inc. dividend yield?

The dividend yield of Lisata Therapeutics Inc. (LSTA) is 0.00%

What is the Market Cap of Lisata Therapeutics Inc.?

The market capitalization of Lisata Therapeutics Inc. (LSTA) is $30.56M

What is Lisata Therapeutics Inc.’s stock symbol?

The stock symbol (or ticker) of Lisata Therapeutics Inc. is LSTA

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top